0001104659-22-002747.txt : 20220110 0001104659-22-002747.hdr.sgml : 20220110 20220110162556 ACCESSION NUMBER: 0001104659-22-002747 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220106 FILED AS OF DATE: 20220110 DATE AS OF CHANGE: 20220110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith L. Mary CENTRAL INDEX KEY: 0001787013 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 22521551 MAIL ADDRESS: STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC. STREET 2: 100 WASHINGTON BLVD. CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm222382d6_4.xml OWNERSHIP DOCUMENT X0306 4 2022-01-06 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001787013 Smith L. Mary C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902 0 1 0 0 Chief Development Officer Common Stock 2022-01-06 4 A 0 22205 A 189716 D Stock Option (Right to Buy) 59.46 2022-01-06 4 A 0 69207 0 A 2032-01-06 Common Stock 69207 69207 D This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on January 6, 2023, another thirty three percent (33%) to vest on January 6, 2024 and the remaining thirty four percent (34%) to vest on January 6, 2025, such that the restricted stock awards are fully vested on January 6, 2025. This option shall vest in 48 equal monthly installments subject to continued service to the company by the Reporting Person. /s/ Francis I. Perier, Jr. as Attorney-in Fact 2022-01-10